Ticker
LGVNCompany Name
LONGEVERON INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 16.75M | $ 10.33M | 61.7% |
3/31/2025 | $ 20.85M | $ 14.33M | 68.72% |
12/31/2024 | $ 25.56M | $ 19.23M | 75.25% |
9/30/2024 | $ 29.91M | $ 22.78M | 76.16% |
6/30/2024 | $ 19.39M | $ 12.38M | 63.81% |
3/31/2024 | $ 9.7M | $ 1.94M | 20.01% |
12/31/2023 | $ 12.08M | $ 4.95M | 40.98% |
9/30/2023 | $ 11.63M | $ 1.97M | 16.92% |
6/30/2023 | $ 17.09M | $ 2.75M | 16.07% |
3/31/2023 | $ 21.81M | $ 4.98M | 22.85% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for LONGEVERON INC is calculated as follows: CashnEq [ $ 1.87M ] / Assets [ $ 10.58M ]
(=) Cash to Assets [ 17.63% ]
Minimum
Dec 31, 2020
Maximum
Sep 30, 2024
Average
Median
filtered constituents | 3.93K |
---|---|
min | 0% |
max | 40.71% |
average | 9.77% |
median | 6.41% |
std | 9.51% |